- Home
- FUN vs OCUL Comparison
FUN vs OCUL Comparison
Compare FUN & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUN
- OCUL
- Stock Information
- Founded
- FUN 1983
- OCUL 2006
- Country
- FUN United States
- OCUL United States
- Employees
- FUN N/A
- OCUL 274
- Industry
- FUN Services-Misc. Amusement & Recreation
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- FUN Consumer Discretionary
- OCUL Health Care
- Exchange
- FUN Nasdaq
- OCUL Nasdaq
- Market Cap
- FUN 2.6B
- OCUL 2.3B
- IPO Year
- FUN 1987
- OCUL 2014
- Fundamental
- Price
- FUN $23.64
- OCUL $12.82
- Analyst Decision
- FUN Buy
- OCUL Strong Buy
- Analyst Count
- FUN 14
- OCUL 6
- Target Price
- FUN $37.64
- OCUL $17.20
- AVG Volume (30 Days)
- FUN 3.8M
- OCUL 2.2M
- Earning Date
- FUN 11-05-2025
- OCUL 08-05-2025
- Dividend Yield
- FUN 5.52%
- OCUL N/A
- EPS Growth
- FUN N/A
- OCUL N/A
- EPS
- FUN N/A
- OCUL N/A
- Revenue
- FUN $3,168,142,000.00
- OCUL $56,664,000.00
- Revenue This Year
- FUN $17.69
- OCUL N/A
- Revenue Next Year
- FUN $5.58
- OCUL $18.87
- P/E Ratio
- FUN N/A
- OCUL N/A
- Revenue Growth
- FUN 67.95
- OCUL N/A
- 52 Week Low
- FUN $21.35
- OCUL $5.79
- 52 Week High
- FUN $49.77
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- FUN 43.63
- OCUL 54.73
- Support Level
- FUN $21.30
- OCUL $12.58
- Resistance Level
- FUN $26.31
- OCUL $13.25
- Average True Range (ATR)
- FUN 1.23
- OCUL 0.58
- MACD
- FUN 0.02
- OCUL -0.03
- Stochastic Oscillator
- FUN 43.71
- OCUL 46.40
About FUN Cedar Fair L.P.
Six Flags Entertainment Corp is North America's regional amusement resort operator with approximately 27 amusement parks, around 15 separately gated water parks, and nine resort properties across the U.S., Canada, and Mexico. It provides coasters, themed rides, thrilling water parks, resorts, and a portfolio of beloved intellectual properties such as Looney Tunes, DC Comics, and PEANUTS.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.